Johnson & Johnson said the first clinical data from its ongoing Phase 1b study of JNJ-4496, a chimeric antigen receptor T-cell therapy, shows encouraging potential in treating large B-cell ...

Shares of Sana Biotechnology jumped after the company reported positive results for the latest study transplanting its UP421 cell therapy into a patient with type 1 diabetes. The stock was up 21% at ...

The process is designed to enable faster and more energy-efficient battery production with a smaller equipment footprint. Compared with its previous Raptor process, Cobra has a heat treatment speed ...

Stem cell therapies are gradually becoming a viable medical option for a range of health conditions. Today, a micro-cap ...

If you are looking for the best dividend stocks to own in 2025, look no further than the Dogs of the Dow. The Dogs of the Dow is a long-standing strategy in which investors seek to benefit from ...

The Dow rose more than 1,000 points, or 2.7%, to close at 39,187. The S&P 500 rose 130 points, or 2.5%, to close at 5,288, while the Nasdaq rose 2.7%.

A month ago, UnitedHealth was the highest-priced stock in the Dow — but now its shares have lost more than 50% of their value.. The Dow is up almost 5% in the same period. That's seemingly good ...